Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
18 auth.
Yixiao Feng,
Mia Spezia,
Shifeng Huang,
Chengfu Yuan,
Z. Zeng,
Linghuan Zhang,
Xiaojuan Ji,
Wei Liu,
Bo Huang,
Wenping Luo,
...
Bo Liu,
Yan Lei,
S. Du,
Akhila Vuppalapati,
H. Luu,
R. Haydon,
T. He,
G. Ren
|
10 |
2018 |
10
2018
|
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
20 auth.
Richard N. Wang,
Jordan D. Green,
Zhongliang Wang,
Youlin Deng,
Min Qiao,
Michael Peabody,
Qian Zhang,
Jixing Ye,
Zhengjian Yan,
S. Denduluri,
...
O. Idowu,
Melissa Li,
Christine Shen,
Alan Hu,
R. Haydon,
Richard W. Kang,
James Mok,
Michael J. Lee,
Hue L. Luu,
Lewis L. Shi
|
9 |
2014 |
9
2014
|
Temozolomide resistance in glioblastoma multiforme
Sang Y Lee
|
9 |
2016 |
9
2016
|
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
14 auth.
U. Anand,
A. Dey,
Arvind K. Singh Chandel,
Rupa Sanyal,
Amarnath Mishra,
D. Pandey,
V. De Falco,
Arun Prakash Upadhyay,
R. Kandimalla,
A. Chaudhary,
...
J. Dhanjal,
S. Dewanjee,
Jayalakshmi Vallamkondu,
J. M. Pérez de la Lastra
|
9 |
2022 |
9
2022
|
3-D bioprinting technologies in tissue engineering and regenerative medicine: Current and future trends
9 auth.
Elliot S. Bishop,
Sami Mostafa,
M. Pakvasa,
H. Luu,
Michael J. Lee,
J. Wolf,
...
G. Ameer,
T. He,
R. Reid
|
8 |
2017 |
8
2017
|
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
22 auth.
Cody S. Lee,
Elliot S. Bishop,
Ruyi Zhang,
Xinyi Yu,
Evan M. Farina,
Shujuan Yan,
Chen Zhao,
Z. Zeng,
Y. Shu,
Xing-ye Wu,
...
J. Lei,
Yasha Li,
Wenwen Zhang,
Chao Yang,
Kevin J. Wu,
Ying Wu,
Sherwin S. Ho,
A. Athiviraham,
Michael J. Lee,
J. Wolf,
R. Reid,
T. He
|
8 |
2017 |
8
2017
|
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
J. Cathcart,
Ashleigh Pulkoski-Gross,
Jian Cao
|
8 |
2015 |
8
2015
|
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Preeti Pachori,
R. Gothalwal,
P. Gandhi
|
8 |
2019 |
8
2019
|
The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
Mohammad Reza Zinatizadeh,
B. Schock,
Ghanbar Mahmoodi Chalbatani,
Peyman Kheirandish Zarandi,
S. Jalali,
S. Miri
|
8 |
2020 |
8
2020
|
Gut microbiota, inflammation and colorectal cancer
Jun Sun,
I. Kato
|
8 |
2016 |
8
2016
|
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance
11 auth.
S. Denduluri,
O. Idowu,
Zhongliang Wang,
Zhan Liao,
Zhengjian Yan,
M. K. Mohammed,
...
Jixing Ye,
Q. Wei,
Jing Wang,
Lianggong Zhao,
H. Luu
|
8 |
2014 |
8
2014
|
The versatile functions of Sox9 in development, stem cells, and human diseases
11 auth.
A. Jo,
S. Denduluri,
Bosi Zhang,
Zhongliang Wang,
L. Yin,
Zhengjian Yan,
...
Richard W. Kang,
Lewis L. Shi,
James Mok,
Michael J. Lee,
R. Haydon
|
8 |
2014 |
8
2014
|
DNA methylation in human diseases
Zelin Jin,
Yun Liu
|
8 |
2018 |
8
2018
|
Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance
19 auth.
M. K. Mohammed,
Connie Shao,
Jing Wang,
Q. Wei,
Xin Wang,
Zach J. Collier,
Shengli Tang,
Hao Liu,
Fugui Zhang,
Jiayi Huang,
...
Dan Guo,
Min-peng Lu,
Feng Liu,
Jian-xiang Liu,
Chao Ma,
Lewis L. Shi,
A. Athiviraham,
T. He,
Michael J. Lee
|
7 |
2016 |
7
2016
|
